Pyc Therapeutics Ltd has released a press release.
AGM Company Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from PYC Therapeutics
- Sept 2018 Quarterly Operations Update and App4C
- Fourfold Delivery Improvement in a New Lead Candidate
- R&D Tax Incentive Refund
- Reinstatement to Official Quotation
- Phylogica Recapitalisation
Later from PYC Therapeutics
- FNA Presentation
- Successful Delivery of CRIPR/Cas9 into Cells ex vivo
- In vivo success - peptide vaccine in Herpes Simplex Virus
- In Vivo Success - peptide vaccine (Amended Graphics)
- CEO letter and Operational Update
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics